Inventor
LICHENSTEIN HENRI
US33 patents
⚠️ This page may combine multiple inventors who share the name “LICHENSTEIN HENRI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AI THERAPEUTICS INC
11 patentsUS11439649B2Sep 13, 2022
Combination therapy with apilimod and glutamatergic agents
AI THERAPEUTICS INC4 citations83
US10751345B2Aug 25, 2020
Combination therapy with apilimod and glutamatergic agents
AI THERAPEUTICS INC5 citations83
US11491143B2Nov 8, 2022
Inhalable rapamycin formulation for the treatment of pulmonary hypertension
AI THERAPEUTICS INC3 citations73
US11103449B2Aug 31, 2021
Inhalable rapamycin formulation for treating age-related conditions
AI THERAPEUTICS INC4 citations73
US10307371B2Jun 4, 2019
Rapamycin for the treatment of lymphangioleiomyomatosis
AI THERAPEUTICS INC6 citations73
US11957688B2Apr 16, 2024
Combination therapy with apilimod and glutamatergic agents
AI THERAPEUTICS INC2 citations72
US11266654B2Mar 8, 2022
Apilimod compositions and methods for using same
AI THERAPEUTICS INC2 citations71
US10350213B2Jul 16, 2019
Methods for treating cancer using apilimod
AI THERAPEUTICS INC4 citations71
US10799508B2Oct 13, 2020
Methods for treating cancer using HSP90 inhibitors
AI THERAPEUTICS INC4 citations70
US11648199B2May 16, 2023
Inhalable rapamycin formulation for treating age-related conditions
AI THERAPEUTICS INC1 citations62
US10729694B2Aug 4, 2020
Anti-viral compositions containing PIKfyve inhibitors and use thereof
AI THERAPEUTICS INC1 citations61
LAM THERAPEUTICS INC
5 patentsUS10307370B2Jun 4, 2019
Rapamycin for the treatment of lymphangioleiomyomatosis
LAM THERAPEUTICS INC6 citations83
US10206910B2Feb 19, 2019
Apilimod for use in the treatment of renal cancer
LAM THERAPEUTICS INC10 citations82
US10765682B2Sep 8, 2020
Apilimod for use in the treatment of melanoma
LAM THERAPEUTICS INC4 citations71
US10179135B2Jan 15, 2019
Apilimod compositions and methods for using same
LAM THERAPEUTICS INC4 citations70
US10702534B2Jul 7, 2020
Compositions and methods relating to the radioprotective effects of apilimod
LAM THERAPEUTICS INC1 citations61
CURAGEN CORP
4 patentsUS6982250B2Jan 3, 2006
Methods of prevention and treatment of inflammatory bowel disease
CURAGEN CORP9 citations72
US7056885B1Jun 6, 2006
Fibroblast growth factor and nucleic acids encoding same
CURAGEN CORP7 citations71
US6916907B1Jul 12, 2005
Nucleic acids encoding osteoprotegern-like proteins and methods of using same
CURAGEN CORP5 citations62
US7253266B2Aug 7, 2007
Polypeptides of FGF-CX
CURAGEN CORP5 citations59
TOPOTARGET UK LTD
4 patentsUS9980957B2May 29, 2018
Histone deacetylase (HDAC) inhibitors for the treatment of cancer
TOPOTARGET UK LTD0 citations47
US9603926B2Mar 28, 2017
Histone deacetylase (HDAC) inhibitors for the treatment of cancer
TOPOTARGET UK LTD0 citations47
US10799469B2Oct 13, 2020
Combination therapies using HDAC inhibitors
TOPOTARGET UK LTD0 citations44
US10285959B2May 14, 2019
Combination therapies using HDAC inhibitors
TOPOTARGET UK LTD0 citations44